Dr Rebecca Andrews

​​I joined the University of Sheffield in 2018 as a doctoral clinical fellow within the Sheffield Myeloma Research Team, working with Dr Andrew Chantry and Dr Michelle Lawson. My PhD focused on exploring effects of both current and novel therapies on myeloma bone disease, with the aim to improve clinical outcomes for myeloma patients.  This work also focussed on understanding the role of osteocyte cells and the lacunae canalicular network in cancer induced bone disease.

Following completion of my doctorate studies, I was successful in securing my current post as a post-graduate bicentennial clinical research fellow, which commenced in November 2024. Throughout this fellowship, I have been involved in the design of clinical trials to investigate new treatment strategies to improve myeloma and myeloma bone disease outcomes. In addition, I have ongoing collaborations on both translational and fundamental projects to further develop our understanding of myeloma bone disease pathophysiology.

Alongside this post I have a clinical role at Sheffield Teaching Hospital as a haematology speciality registrar (MRCP 2016). I have also been involved in the co-authorship of the soon to be published myeloma bone disease national guidelines.

Historically, I initially completed my MBChB at the University of Sheffield in 2012, which included a BMedSci (2009). In 2014 I was successfully awarded a Post-graduate Certificate in Clinical Research. Throughout my career I have been awarded 8 prizes, including a BRS New Investigator Award and a plenary oral award at the international CABS meeting in 2024.

I have been an elected committee member of the Bone Research Society (BRS) since 2024, and have been a member of the society since 2018. I have also been a UK Myeloma Society member since 2018 and a member of the International Myeloma Society since 2025. Locally, I hold a leadership role as a co-organiser of the post-graduate Division Research & Innovation Exchange (DRIvE) seminar series.